ArticleBlood advances2025

Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL.

Rakesh Awasthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.